Variant report

Variant	nsv886917
Chromosome Location	chr6:163507051-163573962
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:163509761..163512247-chr6:163514199..163516689,2	K562	blood:
2	chr6:163554133..163556109-chr6:163556164..163558710,2	K562	blood:
3	chr6:163530518..163532397-chr6:163534746..163536959,2	K562	blood:
4	chr6:163530518..163532397-chr6:163534746..163536959,2	K562	blood:
5	chr6:163539658..163541296-chr6:163542884..163545685,2	K562	blood:
6	chr6:163554133..163556109-chr6:163556164..163558710,2	K562	blood:
7	chr6:163567508..163570798-chr6:163571018..163574333,3	K562	blood:
8	chr6:163509761..163512247-chr6:163514199..163516689,2	K562	blood:
9	chr6:163567508..163570798-chr6:163571018..163574333,3	K562	blood:
10	chr6:163539658..163541296-chr6:163542884..163545685,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL078585.1-9	chr6:163530440-163532004	ucscGeneNc_uc010kkg_1
2	lnc-AL078585.1-9	chr6:163532624-163532824	ucscGeneNc_uc010kkg_1
3	lnc-AL078585.1-9	chr6:163523625-163524579	ucscGeneNc_uc010kkf_1
4	lnc-AL078585.1-9	chr6:163532903-163533024	ucscGeneNc_uc010kkf_1
5	lnc-AL078585.1-9	chr6:163531930-163532004	ucscGeneNc_uc010kkf_1
6	lnc-AL078585.1-9	chr6:163525847-163525940	ucscGeneNc_uc010kkf_1

No data

Extended variants
information (count: 2633 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:2633 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573070	chr6:163507051-163507052	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs372692321	chr6:163507091-163507092	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs574905249	chr6:163507121-163507122	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs543814409	chr6:163507124-163507125	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs193021014	chr6:163507126-163507127	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs529913202	chr6:163507133-163507134	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs76711864	chr6:163507135-163507136	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs560433754	chr6:163507147-163507148	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs147243101	chr6:163507169-163507170	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs528623464	chr6:163507186-163507187	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs146210497	chr6:163507187-163507188	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs75813427	chr6:163507240-163507241	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs140867272	chr6:163507323-163507324	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs182352640	chr6:163507324-163507325	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs571721651	chr6:163507335-163507336	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs547442146	chr6:163507346-163507347	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs545503097	chr6:163507348-163507349	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs144698124	chr6:163507351-163507352	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs374654873	chr6:163507353-163507354	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs531488957	chr6:163507457-163507458	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs375791728	chr6:163507460-163507461	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs567634370	chr6:163507471-163507472	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs520741	chr6:163507487-163507488	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs186681256	chr6:163507490-163507491	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs566766517	chr6:163507492-163507493	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs113059515	chr6:163507615-163507616	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs538810132	chr6:163507624-163507625	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs113429961	chr6:163507650-163507651	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs373099674	chr6:163507655-163507656	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs9456831	chr6:163507685-163507686	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs191879935	chr6:163507689-163507690	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs9456832	chr6:163507696-163507697	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs574966789	chr6:163507701-163507702	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs561904699	chr6:163507755-163507756	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs61228916	chr6:163507909-163507910	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs566102977	chr6:163507937-163507938	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs495882	chr6:163507959-163507960	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs574369212	chr6:163507981-163507982	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs117563946	chr6:163507984-163507985	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs184111798	chr6:163508019-163508020	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs373341895	chr6:163508020-163508021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs56166197	chr6:163508064-163508065	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs79945496	chr6:163508066-163508067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs566177159	chr6:163508087-163508088	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs80127830	chr6:163508089-163508090	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs114029065	chr6:163508090-163508091	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs530940899	chr6:163508102-163508103	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs190162714	chr6:163508182-163508183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs147624118	chr6:163508190-163508191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs375198048	chr6:163508217-163508218	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
abnormal development	18461090	CNVD
Cancer	20164919	CNVD

Chromatin state (count:405 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:163501600-163508400	Weak transcription	Pancreas	Pancrea
2	chr6:163503800-163507400	Enhancers	iPS-18 Cell Line	embryonic stem cell
3	chr6:163503800-163507600	Enhancers	ES-I3 Cell Line	embryonic stem cell
4	chr6:163503800-163507600	Enhancers	HUES6 Cell Line	embryonic stem cell
5	chr6:163504600-163507400	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr6:163504600-163507400	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr6:163505200-163514200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
8	chr6:163506000-163507200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr6:163506200-163507400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr6:163506400-163507200	Enhancers	H1 Cell Line	embryonic stem cell
11	chr6:163506400-163507200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr6:163506400-163507400	Enhancers	Left Ventricle	heart
13	chr6:163506600-163507400	Enhancers	H9 Cell Line	embryonic stem cell
14	chr6:163506800-163507200	Enhancers	Psoas Muscle	Psoas
15	chr6:163506800-163507400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
16	chr6:163506800-163507400	Flanking Active TSS	Fetal Heart	heart
17	chr6:163506800-163507600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr6:163506800-163508200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr6:163507000-163507200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr6:163507000-163507400	Enhancers	Brain Anterior Caudate	brain
21	chr6:163507000-163507400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
22	chr6:163507000-163507600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr6:163507000-163507600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
24	chr6:163507000-163508200	Enhancers	NH-A	brain
25	chr6:163507200-163519400	Weak transcription	H1 Cell Line	embryonic stem cell
26	chr6:163507400-163507600	Enhancers	Fetal Heart	heart
27	chr6:163507400-163507800	Weak transcription	Left Ventricle	heart
28	chr6:163507400-163510000	Weak transcription	HUES48 Cell Line	embryonic stem cell
29	chr6:163507400-163514600	Weak transcription	HUES64 Cell Line	embryonic stem cell
30	chr6:163507400-163514800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
31	chr6:163507400-163515000	Weak transcription	H9 Cell Line	embryonic stem cell
32	chr6:163507600-163507800	Enhancers	Skeletal Muscle Female	skeletal muscle
33	chr6:163507600-163508000	Flanking Active TSS	Fetal Heart	heart
34	chr6:163507800-163508400	Enhancers	Left Ventricle	heart
35	chr6:163507800-163508600	Weak transcription	Skeletal Muscle Female	skeletal muscle
36	chr6:163508000-163508400	Enhancers	Fetal Heart	heart
37	chr6:163508400-163508800	ZNF genes & repeats	Pancreas	Pancrea
38	chr6:163508400-163509000	Flanking Active TSS	Left Ventricle	heart
39	chr6:163508400-163510000	Flanking Active TSS	Fetal Heart	heart
40	chr6:163508600-163508800	Enhancers	Skeletal Muscle Female	skeletal muscle
41	chr6:163508600-163509200	Enhancers	Right Ventricle	heart
42	chr6:163508800-163509000	Enhancers	Psoas Muscle	Psoas
43	chr6:163508800-163520800	Weak transcription	Pancreas	Pancrea
44	chr6:163509000-163509200	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr6:163509000-163509400	Enhancers	Left Ventricle	heart
46	chr6:163509200-163510200	Active TSS	Right Ventricle	heart
47	chr6:163509400-163509600	Flanking Active TSS	Left Ventricle	heart
48	chr6:163509600-163510400	Active TSS	Left Ventricle	heart
49	chr6:163509800-163510000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
50	chr6:163510000-163510200	Active TSS	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links